Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia. (Q45136943)
Jump to navigation
Jump to search
scientific article published on 2 November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia. |
scientific article published on 2 November 2004 |
Statements
Antiretroviral treatment reduces very-low-density lipoprotein and intermediate-density lipoprotein apolipoprotein B fractional catabolic rate in human immunodeficiency virus-infected patients with mild dyslipidemia (English)
Satyajit Das
Michael Stolinski
Fariba Shojaee-Moradie
Nicola C Jackson
William Jefferson
Robert Cramb
Peter Nightingale
A Margot Umpleby
2 November 2004